Cargando…

Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination

SIMPLE SUMMARY: Pancreatic cancer (PDAC) is a highly malignant disease with low survival rates. Due to its close proximity to the insulin producing pancreatic islets, PDAC should be exposed to comparatively higher concentrations of the growth promoting hormone insulin. We wanted to know if PDAC migh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heckl, Steffen M., Kercher, Lukas, Abdullazade, Samir, Schneider, Carolin, Krüger, Sandra, Behrens, Hans-Michael, Sebens, Susanne, Schäfer, Heiner, Schreiber, Stefan, Röcken, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508431/ https://www.ncbi.nlm.nih.gov/pubmed/34638472 http://dx.doi.org/10.3390/cancers13194988

Ejemplares similares

Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control
por: Heckl, Steffen M., et al.
Publicado: (2021)

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
por: Beckinger, Silje, et al.
Publicado: (2023)

Epithelial insulin receptor expression–prognostic relevance in colorectal cancer
por: Heckl, Steffen M., et al.
Publicado: (2018)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023)

The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications
por: Heckl, Steffen M., et al.
Publicado: (2019)

Questioning the IGF1 receptor’s assigned role in CRC – a case for rehabilitation?
por: Heckl, Steffen M., et al.
Publicado: (2020)

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1 / ERBB2 co‐amplification
por: Pries, Katharina, et al.
Publicado: (2023)

Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer
por: Hoffmann, Anne, et al.
Publicado: (2021)

Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells †
por: Sandforth, Leontine, et al.
Publicado: (2020)

LAG3 in gastric cancer: it’s complicated
por: Ulase, Dita, et al.
Publicado: (2023)

How two sites of inflammation promote carcinogenesis: The role of macrophages in inflammation associated carcinogenesis
por: Sebens, Susanne, et al.
Publicado: (2012)

The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cells
por: Grage-Griebenow, Evelin, et al.
Publicado: (2014)

The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1
por: Genrich, Geeske, et al.
Publicado: (2016)

Inflammation Associated Pancreatic Tumorigenesis: Upregulation of Succinate Dehydrogenase (Subunit B) Reduces Cell Growth of Pancreatic Ductal Epithelial Cells
por: Rahn, Sascha, et al.
Publicado: (2019)

Cytoprotection “gone astray”: Nrf2 and its role in cancer
por: Geismann, Claudia, et al.
Publicado: (2014)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells
por: Arfmann-Knübel, Sarah, et al.
Publicado: (2015)

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions
por: Pfeifer, Marco, et al.
Publicado: (2010)

POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma
por: Rahn, Sascha, et al.
Publicado: (2019)

At wit's end /
por: Bombeck, Erma
Publicado: (1975)

Expert witness
por: Parakh, SC
Publicado: (2011)

Appeal for witnesses
por: Claude Lamboley
Publicado: (2010)

Witnessing consciousness
por: Krishnacharya, Prabhakar Srinivasapuram
Publicado: (2016)

The Medical Witness
Publicado: (1903)

Expert Witnesses
Publicado: (1898)

...The Soul of Wit
Publicado: (1997)

Medical Witness
por: Field, D. L.
Publicado: (1905)

The Medical Witness
Publicado: (1899)

Witnesses Three
Publicado: (1863)

An Erring Witness
Publicado: (1876)

English Wit
Publicado: (1889)

Intergenerational effects of witnessing domestic violence: Health of the witnesses and their children
por: Forke, Christine M., et al.
Publicado: (2019)

Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism
por: Ammar, Nourhane, et al.
Publicado: (2023)

NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023)

Mature cystic teratoma of the ovary: a cutting edge overview on imaging features
por: Sahin, Hilal, et al.
Publicado: (2017)

Wit Stwosz : Oltarz krakowski.
Publicado: (1964)

Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts
por: Gürgen, Dennis, et al.
Publicado: (2022)

WIT Women in Technology
por: Caraban Gonzalez, Noemi
Publicado: (2019)

Women's wit and wisdom.
Publicado: (1991)

The Doctor in the Witness-Box
por: Belford, A. J.
Publicado: (1935)

Cannot write session to /tmp/vufind_sessions/sess_4vpdsv0c18bbf5nu3uv79ctuus